ES8202031A1 - Procedimiento para la obtencion de derivados de piranosa - Google Patents

Procedimiento para la obtencion de derivados de piranosa

Info

Publication number
ES8202031A1
ES8202031A1 ES499420A ES499420A ES8202031A1 ES 8202031 A1 ES8202031 A1 ES 8202031A1 ES 499420 A ES499420 A ES 499420A ES 499420 A ES499420 A ES 499420A ES 8202031 A1 ES8202031 A1 ES 8202031A1
Authority
ES
Spain
Prior art keywords
formula
intermediates
derivatives
aldohexoses
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES499420A
Other languages
English (en)
Other versions
ES499420A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8202031A1 publication Critical patent/ES8202031A1/es
Publication of ES499420A0 publication Critical patent/ES499420A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE DERIVADOS DE PIRANOSA DE FORMULA (I), DONDE R ES HIDROXI, AMINO U OTROS, R15 HIDROGENO O ALQUILO INFERIOR, R1 Y R4 HIDROGENO, ACILO O UN GRUPO PROTECTOR HIDROXI, R2 ALQUILO, ARILO O ALCOXI, ETC. SE PARTE DE UN COMPUESTO DE FORMULA (I) CON LOS GRUPOS FUNCIONALES PROTEGIDOS. SE DISOCIA HIDROGENOLITICAMENTE O FOTOLITICAMENTE AL MENOS UN GRUPO SUSTITUIBLE POR HIDROGENO, EN CONDICIONES SOLVOLITICAS, DEBILMENTE ACIDAS, O BIEN SE TRANSFORMA AL MENOS UN GRUPO FUNCIONAL EN LOS DERIVADOS CORRESPONDIENTE A LOS PRODUCTOS FINALES. OPCIONALMENTE, SE OBTIENE EL PRODUCTO POR AMIDIZACION DE UN COMPUESTO DE FORMULA (II), CUYOS GRUPOS FUNCIONALES PUEDEN ESTAR PROTEGIDOS, Y EVENTUALMENTE TRANSFORMANDO LOS GRUPOS PROTEGIDOS EN GRUPOS LIBRES.
ES499420A 1980-02-15 1981-02-13 Procedimiento para la obtencion de derivados de piranosa Granted ES499420A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH126580 1980-02-15

Publications (2)

Publication Number Publication Date
ES8202031A1 true ES8202031A1 (es) 1982-01-01
ES499420A0 ES499420A0 (es) 1982-01-01

Family

ID=4206350

Family Applications (1)

Application Number Title Priority Date Filing Date
ES499420A Granted ES499420A0 (es) 1980-02-15 1981-02-13 Procedimiento para la obtencion de derivados de piranosa

Country Status (21)

Country Link
US (1) US4406889A (es)
EP (1) EP0034347B1 (es)
JP (1) JPS56128794A (es)
KR (3) KR850000077B1 (es)
AT (1) ATE19087T1 (es)
AU (1) AU544636B2 (es)
CA (1) CA1181393A (es)
DD (1) DD159341A5 (es)
DE (1) DE3174293D1 (es)
DK (1) DK65281A (es)
ES (1) ES499420A0 (es)
FI (1) FI72733C (es)
GB (1) GB2070619B (es)
GR (1) GR73555B (es)
HU (1) HU194910B (es)
IE (1) IE50899B1 (es)
IL (1) IL62133A (es)
NO (1) NO151325C (es)
NZ (1) NZ196261A (es)
PT (1) PT72500B (es)
ZA (1) ZA81969B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57144225A (en) * 1981-03-04 1982-09-06 Tadao Kokubu Antigenetic preparation for treating nonspecific allergic diseases and its preparation
EP0102319B1 (de) * 1982-07-23 1987-08-19 Ciba-Geigy Ag Verwendung von Muramylpeptiden oder deren Analogen zur Prophylaxe und Therapie von Virusinfektionen
US4550086A (en) * 1983-02-16 1985-10-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies that recognize human T cells
EP0118364B1 (en) * 1983-03-04 1987-07-29 Merck & Co. Inc. Immunostimulatory dipeptidyl d-glucose derivatives and methods of preparation
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4631343A (en) * 1983-11-07 1986-12-23 Eli Lilly And Company Cyanopyrazole intermediates
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
PT80531B (de) * 1984-05-29 1987-04-06 Ciba Geigy Ag Verfahren zur herstellung acylerter zuckerderivate
JPS6157597A (ja) * 1984-08-29 1986-03-24 Toshiyuki Hamaoka ムラミルペプチド活性エステル誘導体
US4640911A (en) * 1985-05-29 1987-02-03 Ciba-Geigy Corporation Acylated sugar derivatives, processes for their manufacture, and their use
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US7847093B2 (en) * 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
ES2534947T3 (es) 2009-03-25 2015-04-30 The Board Of Regents Of The University Of Texas System Composiciones para la estimulación de resistencia inmunitaria innata de mamíferos a patógenos
WO2016044839A2 (en) 2014-09-19 2016-03-24 The Board Of Regents Of The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
MX2020002010A (es) 2017-08-21 2020-07-13 Celgene Corp Procesos para la preparacion de 4,5-diamino-5-oxopentanoato de (s)-terc-butilo.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
FR2343482A1 (fr) * 1976-03-10 1977-10-07 Anvar La 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-seryl-d-isoglutamine et medicaments la contenant
US4082736A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
US4082735A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
CH636887A5 (en) * 1976-04-26 1983-06-30 Syntex Inc Process for the preparation of novel immunological adjuvant compounds
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
JPS5479228A (en) * 1977-12-02 1979-06-25 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
EP0003833B2 (de) 1978-02-24 1990-12-19 Ciba-Geigy Ag Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
CA1185237A (en) * 1979-02-28 1985-04-09 Yuichi Yamamura 6-deoxyglucosamine-peptide derivatives, their production and use

Also Published As

Publication number Publication date
DK65281A (da) 1981-08-16
KR850000063B1 (ko) 1985-02-15
KR850000077B1 (ko) 1985-02-18
CA1181393A (en) 1985-01-22
ES499420A0 (es) 1982-01-01
IE50899B1 (en) 1986-08-06
AU6728481A (en) 1981-08-20
EP0034347A2 (de) 1981-08-26
GB2070619B (en) 1983-07-06
NO151325B (no) 1984-12-10
GB2070619A (en) 1981-09-09
NZ196261A (en) 1984-05-31
FI72733B (fi) 1987-03-31
KR830005257A (ko) 1983-08-03
PT72500A (en) 1981-03-01
AU544636B2 (en) 1985-06-06
NO151325C (no) 1985-03-20
ATE19087T1 (de) 1986-04-15
FI810461L (fi) 1981-08-16
GR73555B (es) 1984-03-15
DE3174293D1 (en) 1986-05-15
PT72500B (en) 1982-02-05
FI72733C (fi) 1987-07-10
IL62133A0 (en) 1981-03-31
IL62133A (en) 1985-04-30
KR850000064B1 (ko) 1985-02-15
HU194910B (en) 1988-03-28
NO810500L (no) 1981-08-17
EP0034347B1 (de) 1986-04-09
DD159341A5 (de) 1983-03-02
EP0034347A3 (en) 1981-11-18
ZA81969B (en) 1982-09-29
JPS56128794A (en) 1981-10-08
US4406889A (en) 1983-09-27
IE810296L (en) 1981-08-15

Similar Documents

Publication Publication Date Title
ES8202031A1 (es) Procedimiento para la obtencion de derivados de piranosa
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
HUT57722A (en) Process for producing azaspiran derivatives and pharmaceutical compositions comprising such compounds
ES8406881A1 (es) Procedimiento para la preparacion de 4-amino-metileno-cromanos y -cromenos sustituidos
IL86133A (en) Beta-d-phenylthioxylosides,their preparation and pharmaceutical compositions containing them
IL62198A0 (en) 3,4,5-trihydroxypiperidine compounds,their production and pharmaceutical compositions containing them
IL66423A0 (en) Derivatives of 4-methyl 6-phenylpyridazine and pharmaceutical compositions containing them
EP0027908A3 (en) 2-hydroxyalkyl-3,4,5,trihydroxy piperidines, processes for their preparation and their use as medicaments
IE873280L (en) Carbamoylimidazole derivatives, a process for their¹preparation, and their use as fungicides
DE3466991D1 (en) Penems, pharmaceutical compositions containing them, and process for their preparation
ES8609319A1 (es) Procedimiento de preparacion de nuevas fenil-naftiridinas.
ES8103112A1 (es) Procedimiento para la obtencion de pseudo-trisacaridos
ES8200689A1 (es) Un procedimiento para la produccion de analogos de cefalosporina.
WO1989010929A3 (fr) Nouveaux analogues du l-fucose, leur procede de preparation, application de ces analogues a la preparation de nouveaux glycals, anthracyclines obtenues a l'aide de ces glycals et utilisation desdites anthracyclines en tant que medicaments
SE8302394D0 (sv) Nya modifierade leror, framstellning derav och terapeutiska kompositioner innehallande dessa
EP0345719A3 (en) Compounds containing at least three functional ester groups, and process for their preparation
ES8200348A1 (es) Procedimiento para la preparacion de nuevas propargil-tio- nitropiridinas
JPS562997A (en) Preparation of aminoglycoside, and novel aminoglycoside
JPS56133260A (en) Azetidine derivative and its preparation
JPS5675443A (en) Novel allyl alcohol
ES8401987A1 (es) Procedimiento para la obtencion de nuevos n-metilcarbamatos n-carboxilados.